TTC30B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.848200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.814200E-01
Normal-vs-Stage2
5.375800E-01
Normal-vs-Stage3
2.857200E-01
Normal-vs-Stage4
7.176600E-01
Stage1-vs-Stage2
2.758200E-01
Stage1-vs-Stage3
1.611770E-02
Stage1-vs-Stage4
6.576200E-01
Stage2-vs-Stage3
4.790900E-04
Stage2-vs-Stage4
1.218010E-01
Stage3-vs-Stage4
2.105600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.317200E-01
Normal-vs-AfricanAmerican
7.197400E-01
Normal-vs-Asian
9.578200E-01
Caucasian-vs-AfricanAmerican
7.218000E-01
Caucasian-vs-Asian
5.781200E-01
AfricanAmerican-vs-Asian
7.910400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.978200E-01
Normal-vs-Female
7.152200E-01
Male-vs-Female
2.404000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.991200E-01
Normal-vs-Age(41-60Yrs)
9.930800E-01
Normal-vs-Age(61-80Yrs)
3.723000E-01
Normal-vs-Age(81-100Yrs)
2.986200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.061400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.872800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.172000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.665830E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.951900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.796800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.742220E-01
Normal-vs-Daily Drinker
7.576000E-02
Normal-vs-Weekly Drinker
1.747810E-01
Normal-vs-Occasional Drinker
7.701600E-01
Normal-vs-Social Drinker
9.265400E-01
Non Drinker-vs-Daily Drinker
5.073200E-01
Non Drinker-vs-Weekly Drinker
7.288600E-01
Non Drinker-vs-Occasional Drinker
4.584000E-02
Non Drinker-vs-Social Drinker
2.841500E-02
Daily Drinker-vs-Weekly Drinker
8.408000E-01
Daily Drinker-vs-Occasional Drinker
2.594000E-02
Daily Drinker-vs-Social Drinker
8.797900E-03
Weekly Drinker-vs-Occasional Drinker
3.745700E-02
Weekly Drinker-vs-Social Drinker
4.530400E-02
Occasional Drinker-vs-Social Drinker
4.440800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.487600E-02
Normal-vs-Grade 2
1.083550E-01
Normal-vs-Grade 3
2.408100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.971600E-01
Grade 1-vs-Grade 3
2.852200E-01
Grade 1-vs-Grade 4
7.487600E-02
Grade 2-vs-Grade 3
3.746000E-01
Grade 2-vs-Grade 4
1.083550E-01
Grade 3-vs-Grade 4
2.408100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.192220E-01
Normal-vs-NonDiabetic
6.612000E-01
Diabetic-vs-NonDiabetic
7.501800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.400200E-01
Normal-vs-NoPancreatitis
5.784800E-01
Pancreatitis-vs-NoPancreatitis
3.711200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.759400E-01
Normal-vs-N1
5.803600E-01
N0-vs-N1
9.967400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.930400E-01
Normal-vs-TP53-NonMutant
7.585400E-01
TP53-Mutant-vs-TP53-NonMutant
3.868000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
